Skip to content

Drug interactions

Eplerenone + Lenacapavir

Severity: Moderate

Eplerenone and Lenacapavir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenacapavir is a moderate CYP3A4 inhibitor whose effect persists for months after subcutaneous dosing. Eplerenone exposure may increase, raising hyperkalemia risk.

What this interaction means in plain words

Eplerenone and Lenacapavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eplerenone belongs to Cardiovascular; Lenacapavir belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4 by lenacapavir reduces eplerenone clearance.

What to do

Monitor serum potassium and renal function, and keep eplerenone at a reduced dose consistent with moderate CYP3A4 inhibitor labeling.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eplerenone and Lenacapavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eplerenone with Lenacapavir?

MediHelp rates the interaction as moderate. Eplerenone and Lenacapavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lenacapavir is a moderate CYP3A4 inhibitor whose effect persists for months after subcutaneous dosing. Eplerenone exposure may increase, raising hyperkalemia risk.

How serious is the interaction between Eplerenone and Lenacapavir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium and renal function, and keep eplerenone at a reduced dose consistent with moderate CYP3A4 inhibitor labeling.

What other medicines interact with Eplerenone?

MediHelp also lists interactions of Eplerenone with, for example, Amiloride, Atazanavir, Clarithromycin. The full list is on the Eplerenone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in